Sources: 
Chronos Capital is making a significant strategic shift by betting heavily on artificial intelligence in healthcare, anticipating a transformative surge in the sector.
With $467 million (R8.3 billion) in assets under management, the firm is focusing on long-term, scalable investments where AI is deeply embedded in the value chain.
"AI in healthcare is where fintech was in financial services 30 years ago," said partner Roger Grobler, emphasizing the vast growth potential still ahead.
Chronos has a proven track record as an early investor in disruptive companies such as Tyme Group and Optasia. Tyme Bank, a digital lender operating across South Africa, the Philippines, and Vietnam, is now valued at over $1 billion.
Similarly, Optasia, a Dubai-based fintech offering micro-loans in 40 countries, recently reached a $1 billion valuation.
This experience underpins Chronos's confidence in AI healthcare startups, which it views as the next frontier for innovation and value creation in global medicine.
By leveraging its expertise in fintech and applying it to healthcare, Chronos aims to capitalize on the transformative potential of AI technologies to improve patient outcomes and healthcare delivery worldwide.
The firm's strategic pivot signals a broader trend of investment firms recognizing AI's disruptive power beyond traditional sectors, positioning Chronos as a key player in the future of healthcare innovation.
Sources: Chronos Capital, managing $467 million in assets, is pivoting to AI healthcare startups, viewing the sector as a transformative force akin to fintech's rise 30 years ago. The firm, early investor in Tyme Group and Optasia, targets scalable, long-term AI-driven healthcare innovations globally.
